BR112015033065A8 - nanopartícula de lipídio; composição farmacêutica; e uso da nanopartícula de lipídio - Google Patents

nanopartícula de lipídio; composição farmacêutica; e uso da nanopartícula de lipídio

Info

Publication number
BR112015033065A8
BR112015033065A8 BR112015033065A BR112015033065A BR112015033065A8 BR 112015033065 A8 BR112015033065 A8 BR 112015033065A8 BR 112015033065 A BR112015033065 A BR 112015033065A BR 112015033065 A BR112015033065 A BR 112015033065A BR 112015033065 A8 BR112015033065 A8 BR 112015033065A8
Authority
BR
Brazil
Prior art keywords
lipid nanoparticle
pharmaceutical composition
nanoparticle
lipid
pharmaceutical
Prior art date
Application number
BR112015033065A
Other languages
English (en)
Other versions
BR112015033065B1 (pt
Inventor
Esquisabel Alegria Amaya
Del Pozo Perez Angel
Bachiller Perez Daniel
Fuste Dominguez Ester
Sans Serramit Jana Eulalia
Gainza Lafuente Eusebio
Gainza Lucea Garazi
Gil Martin Iraida
Luis Pedraz Muñoz José
Pastor Navarro Marta
Ibarrola Moreno Oihane
Fernandez Plagaro Raúl
Villullas Rincon Silvia
Original Assignee
Biopraxis Res Aie
Consejo Superior Investigacion
Fund Dinvestigacio Sanitaria De Les Illes Balears
Praxis Pharmaceutical S A
Univ Barcelona
Univ Del Pais Vasco/Euskal Herriko Unibertsitatea
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biopraxis Res Aie, Consejo Superior Investigacion, Fund Dinvestigacio Sanitaria De Les Illes Balears, Praxis Pharmaceutical S A, Univ Barcelona, Univ Del Pais Vasco/Euskal Herriko Unibertsitatea filed Critical Biopraxis Res Aie
Publication of BR112015033065A8 publication Critical patent/BR112015033065A8/pt
Publication of BR112015033065B1 publication Critical patent/BR112015033065B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR112015033065-7A 2013-07-03 2014-07-02 Nanopartícula de lipídio; composição farmacêutica; e uso da nanopartícula de lipídio BR112015033065B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13382268.4 2013-07-03
EP13382268 2013-07-03
PCT/ES2014/070538 WO2015001160A1 (es) 2013-07-03 2014-07-02 Nanopartícula lipídica de polimixina

Publications (2)

Publication Number Publication Date
BR112015033065A8 true BR112015033065A8 (pt) 2018-01-23
BR112015033065B1 BR112015033065B1 (pt) 2022-12-20

Family

ID=48917472

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015033065-7A BR112015033065B1 (pt) 2013-07-03 2014-07-02 Nanopartícula de lipídio; composição farmacêutica; e uso da nanopartícula de lipídio

Country Status (8)

Country Link
US (1) US9919027B2 (pt)
EP (1) EP3017823B1 (pt)
JP (1) JP2016525506A (pt)
CN (1) CN105517560A (pt)
BR (1) BR112015033065B1 (pt)
ES (1) ES2726849T3 (pt)
RU (1) RU2016103313A (pt)
WO (1) WO2015001160A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2821077A1 (en) * 2013-07-04 2015-01-07 Praxis Biopharma Research Institute Lipid nanoparticles for wound healing
CN104721809A (zh) * 2015-03-12 2015-06-24 内蒙古金河动物药业有限公司 一种包含硫酸黏菌素的药物组合物及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1129705A1 (en) * 2000-02-17 2001-09-05 Rijksuniversiteit te Groningen Powder formulation for inhalation
US6653319B1 (en) * 2001-08-10 2003-11-25 University Of Kentucky Research Foundation Pharmaceutical formulation for poorly water soluble camptothecin analogues
US20060222716A1 (en) * 2005-04-01 2006-10-05 Joseph Schwarz Colloidal solid lipid vehicle for pharmaceutical use
US20090169635A1 (en) 2007-12-31 2009-07-02 Alpharx Inc. Pharmaceutical compositions and use thereof
ES2384060B1 (es) * 2010-03-24 2013-09-23 Lipotec S.A. Cápsulas de nanopartículas lipídicas.
WO2012061902A1 (en) * 2010-11-12 2012-05-18 Monash University Micronised spray-dried particles comprising polymyxin

Also Published As

Publication number Publication date
EP3017823A1 (en) 2016-05-11
CN105517560A (zh) 2016-04-20
RU2016103313A (ru) 2017-08-08
US9919027B2 (en) 2018-03-20
ES2726849T3 (es) 2019-10-09
US20160113995A1 (en) 2016-04-28
JP2016525506A (ja) 2016-08-25
BR112015033065B1 (pt) 2022-12-20
WO2015001160A1 (es) 2015-01-08
EP3017823B1 (en) 2019-02-20

Similar Documents

Publication Publication Date Title
CY2018022I1 (el) Πολυκυκλικες ενωσεις καρβαμοϋλπυριδονης και φαρμακευτικη χρηση αυτων
FR21C1059I2 (fr) Compositions pharmaceutiques
DK3030262T3 (da) Kombineret farmaceutisk sammensætning
CL2015003440A1 (es) Composiciones de arni contra tmprss6 y métodos para su uso
DK3181128T3 (da) Farmaceutisk nilotinib-sammensætning
BR112015001600A2 (pt) emulsão e uso de um éster
ES2972419T3 (es) Inhibidores de quinurenina-3-monooxigenasa, composiciones farmacéuticas y métodos de uso de los mismos
BR112013014644A2 (pt) composição farmacêutica e complexo
BR112015016548A2 (pt) polimixinas , composições , métodos de preparação e métodos de uso
DK3079655T3 (da) Inhalerbare lægemidler
EP2995308A4 (en) ANTI-HYPOXIC PHARMACEUTICAL COMPOSITION AND USE THEREOF
CL2016001209A1 (es) Agentes anticancerosos y sus preparaciones
FI20125888A (fi) Anisomelihapon farmaseuttiset koostumukset ja niiden käyttö
HK1219691A1 (zh) 醫藥組成物及其用途
SMT201700004B (it) Uso di estratti di salvia haenkei in composizioni per antisenescenza
BR112015002646A2 (pt) composto e composição farmacêutica
DK3003401T3 (da) Farmaceutisk præparat
BR112015023621A2 (pt) derivados de menopenem e usos dos mesmos
DK2954894T3 (da) Stabilt og lyofiliseret farmaceutisk middel indeholdende nocathiacin
CL2016000231A1 (es) Preparados y formación de preparados usados en tecnología de concreto
BR112015033065A8 (pt) nanopartícula de lipídio; composição farmacêutica; e uso da nanopartícula de lipídio
BR112014017217A2 (pt) agente e composição farmacêutica
FR3007291B1 (fr) Composition cicatrisante et utlisation
GB201307082D0 (en) Pharmaceutical composition comprising 15-HETrE and methods of using the same
BR112014026880A2 (pt) composição de sensibilização e método de uso

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 02/07/2014, OBSERVADAS AS CONDICOES LEGAIS